Messinger, Y <br/><br/>
Evaluation of temozolomide in a SCID mouse model of human B-cell precursor leukemia.  [electronic resource] 

 -  Leukemia & lymphoma  Apr 1999 
 - 289-93 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428199909058428  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Burkitt Lymphoma--drug therapy<br/>Combined Modality Therapy<br/>Dacarbazine--analogs & derivatives<br/>Humans<br/>Immunotoxins--therapeutic use<br/>Mice<br/>Mice, SCID<br/>N-Glycosyl Hydrolases<br/>Plant Proteins--therapeutic use<br/>Ribosome Inactivating Proteins, Type 1<br/>Temozolomide<br/>Time Factors<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured